Brain
Proteins Linked
to Parkinson's Disease
Excerpt
By Keith
Mulvihill, Reuter's Health
NEW YORK (Reuters Health) - Two naturally occurring proteins
in the brain may combine to wreak havoc on normal brain function
and contribute to Parkinson's disease onset, according to a report
in the June issue of the journal Nature Medicine.
The conclusions are based on studies involving cultures of human
brain nerve cells.
Parkinson's disease is marked by the loss of brain cells that
produce the chemical dopamine, leading to symptoms such as tremor,
rigidity and stiffness, slowed movement, and problems with balance
and coordination. The exact cause is unknown, but many researchers
believe that a combination of environmental factors, genetics
and aging are at work.
The new study points to specific molecules that may cause the
dopamine-producing neurons to die in the brains of patients with
Parkinson's disease, explained lead investigator Dr. Bruce A.
Yankner of The Children's Hospital in Boston, Massachusetts, during
an interview with Reuters Health.
"It suggests that two proteins--alpha-synuclein and another
protein called 14-3-3--may come together in a lethal combination,
which could contribute to the development of Parkinson's disease,"
he said.
The researchers found that a protein complex containing the
two substances could trigger a cell suicide mechanism in dopamine-producing
nerve cells, but actually protected other types of nerve cells.
Until now, the combination of alpha-synuclein with 14-3-3 protein
was not previously known to cause nerve cell degeneration, Yankner
noted.
While the normal function of alpha-synuclein in the brain is
unknown, the findings suggest that it may act to protect the brain,
Yankner pointed out. "However, for unclear reasons, this protective
function may be subverted to a detrimental toxic function in Parkinson's
disease," he said.
"It is too early to make any clear predictions regarding treatment,"
Yankner said. "However, if the findings of this paper prove to
be important for Parkinson's disease, then preventing alpha-synuclein
from getting together with the 14-3-3 protein could be a new therapeutic
approach to the disease."
SOURCE: Nature Medicine 2002;8:600-606.
Reference
Source 89
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|